MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Alimera Sciences Company Profile (NASDAQ:ALIM)

Consensus Ratings for Alimera Sciences (NASDAQ:ALIM) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (210.08% upside)

Analysts' Ratings History for Alimera Sciences (NASDAQ:ALIM)
Show:
DateFirmActionRatingPrice TargetActions
8/11/2015Cantor FitzgeraldReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Cantor FitzgeraldSet Price TargetBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Cantor FitzgeraldReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Cantor FitzgeraldInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Summer StreetInitiated CoverageBuy -> Buy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2014Northland SecuritiesBoost Price TargetOutperform$7.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Northland SecuritiesBoost Price Target$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2013Cowen and CompanyUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2013Northland SecuritiesInitiated CoverageOutperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2013Northland SecuritiesInitiated CoverageOutperform$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha